Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis
The newer, sirolimus DCB was noninferior on angiography, but additional clinical studies with longer follow-up are needed.
Source: tctmd.com
Sequent Please Neo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sequent Please Neo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sequent Please Neo Today - Breaking & Trending Today
Comparing DCBs in De Novo CAD: Drugs, Design Matter
At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about 6-month late lumen loss.
Source: tctmd.com
Comparing DCBs in De Novo CAD: Drugs, Design Matters
At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about 6-month late lumen loss.
Source: tctmd.com
TRANSFORM 1 enrollment completed: A crucial RCT ready to redefine the DCB Angioplasty Mechanism
Birmingham [England], September 14 (ANI/PRNewswire): Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch Sirolimus Coated Balloon). The Randomized Controlled Trial (RCT) was conceptualized with the aim of understanding how the treatment indications and applications of Drug-Coated Balloon (DCB) in coronary artery disease (CAD) can be broadened. This prospective, randomized, multi-centre, RCT focusing on small vessels, de-novo coronary lesion treatment enrolled the culminating 114th patient on...
Source: laosnews.net
Concept Medical Inc.: TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism
BIRMINGHAM, England, Sept. 13, 2022 /PRNewswire/ -- Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial
Source: finanznachrichten.de